Cite
Mazidi T, Rouini MR, Ghahremani MH, et al. Impact of UGT1A9 Polymorphism on Mycophenolic Acid Pharmacokinetic Parameters in Stable Renal Transplant Patients. Iran J Pharm Res. 2013;12(3):547-56
Mazidi, T., Rouini, M. R., Ghahremani, M. H., Dashti-Khavidaki, S., Lessan-Pezeshki, M., Ahmadi, F. L., Salam-Zadeh, J., Mandegary, A., & Gholami, K. (2013). Impact of UGT1A9 Polymorphism on Mycophenolic Acid Pharmacokinetic Parameters in Stable Renal Transplant Patients. Iranian journal of pharmaceutical research : IJPR, 12(3), 547-56.
Mazidi, Talia, et al. "Impact of UGT1A9 Polymorphism on Mycophenolic Acid Pharmacokinetic Parameters in Stable Renal Transplant Patients." Iranian journal of pharmaceutical research : IJPR vol. 12,3 (2013): 547-56.
Mazidi T, Rouini MR, Ghahremani MH, Dashti-Khavidaki S, Lessan-Pezeshki M, Ahmadi FL, Salam-Zadeh J, Mandegary A, Gholami K. Impact of UGT1A9 Polymorphism on Mycophenolic Acid Pharmacokinetic Parameters in Stable Renal Transplant Patients. Iran J Pharm Res. 2013;12(3):547-56. PMID: 24250661; PMCID: PMC3813283.
Copy
Download .nbib